FLR
56
-2
LEN
57
-4
SO
62
3
PCG
93
4
HAL
62
-2
NEE
59
5
PNW
70
3
GWW
76
2
ABBV
50
8
WY
60
-2
ALL
51
3
VTR
55
8
SRE
45
-9
FOXA
53
3
AMZN
59
3
SIG
50
-5
DOV
69
2
JWN
59
2
CMS
64
4
RF
67
-2
FLR
56
-2
LEN
57
-4
SO
62
3
PCG
93
4
HAL
62
-2
NEE
59
5
PNW
70
3
GWW
76
2
ABBV
50
8
WY
60
-2
ALL
51
3
VTR
55
8
SRE
45
-9
FOXA
53
3
AMZN
59
3
SIG
50
-5
DOV
69
2
JWN
59
2
CMS
64
4
RF
67
-2
Financhill
Back

China Construction Bank Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
21

CICHF
China Construction Bank

Last Price:
0.71
Seasonality Move:
1.39%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
130.47
Seasonality Move:
14.88%
Sell
21
China Construction Bank (CICHF) is a Sell

Is China Construction Bank a Buy, Sell or Hold?

  • The current China Construction Bank [CICHF] share price is $0.71. The Score for CICHF is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • CICHF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CICHF Stock Price Chart

What is China Construction Bank's stock price today?

  • The China Construction Bank share price today is $0.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CICHF is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CICHF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 41.74 Sell
Chaikin Money Flow: -29940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.73 - 0.77) Sell
Bollinger Bands (100): (0.68 - 0.76) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

CICHF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.74 Sell
20-day SMA: 0.76 Sell
50-day SMA: 0.75 Sell
200-day SMA: 0.69 Buy
8-day EMA: 0.74 Sell
20-day EMA: 0.75 Sell
50-day EMA: 0.75 Sell
200-day EMA: 0.7 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

China Construction Bank Earnings Growth & CICHF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

China Construction Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):